Literature DB >> 7775643

3-Monoglucuronyl-glycyrrhetinic acid is a major metabolite that causes licorice-induced pseudoaldosteronism.

H Kato1, M Kanaoka, S Yano, M Kobayashi.   

Abstract

18 beta-Glycyrrhetinic acid (GA) has been thought to be one of the major metabolites that causes licorice-induced pseudoaldosteronism. However, we found no difference in the blood level of GA between the patients with and without pseudoaldosteronism. We measured the blood concentration of 3 beta-D-(monoglucuronyl)18 beta-glycyrrhetinic acid (3MGA), another metabolite of 3 beta-D-diglucuronyl-18 beta-glycyrrhetinic acid (glycyrrhizin), by high performance liquid chromatography and found an increased concentration of 3MGA in 10 patients with licorice-induced pseudoaldosteronism, but not in 11 patients without pseudoaldosteronism. To investigate whether 3MGA can inhibit 11 beta-hydroxysteroid dehydrogenase, we incubated rat renal microsome with or without 3MGA and measured the conversion rate of [3H]cortisol to [3H]cortisone. 3MGA was found to be a potent inhibitor of 11 beta-hydroxysteroid dehydrogenase, allowing cortisol to exert its full mineralocorticoid effects. These results suggest that licorice-induced pseudoaldosteronism is due to an increased concentration of 3MGA, but not GA, in the circulating blood of these patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775643     DOI: 10.1210/jcem.80.6.7775643

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  Glycyrrhizin ameliorates metabolic syndrome-induced liver damage in experimental rat model.

Authors:  Rajarshi Sil; Doel Ray; Abhay Sankar Chakraborti
Journal:  Mol Cell Biochem       Date:  2015-09-23       Impact factor: 3.396

2.  Torsades de Pointes induced by a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs during hypokalemia due to licorice.

Authors:  Kanyu Miyamoto; Hirohisa Kawai; Ryuhei Aoyama; Hitoshi Watanabe; Keisuke Suzuki; Norihiro Suga; Wataru Kitagawa; Naoto Miura; Kazuhiro Nishikawa; Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2009-11-14       Impact factor: 2.801

Review 3.  Research progress on the protective effects of licorice-derived 18β-glycyrrhetinic acid against liver injury.

Authors:  Shou-Yan Wu; Wen-Jie Wang; Jin-Hui Dou; Li-Kun Gong
Journal:  Acta Pharmacol Sin       Date:  2020-03-06       Impact factor: 6.150

4.  Effects of shakuyakukanzoto and its absorbed components on twitch contractions induced by physiological Ca2+ release in rat skeletal muscle.

Authors:  Noriko Kaifuchi; Yuji Omiya; Hirotaka Kushida; Miwako Fukutake; Hiroaki Nishimura; Yoshio Kase
Journal:  J Nat Med       Date:  2015-03-18       Impact factor: 2.343

5.  18β-glycyrrhetyl-3-O-sulfate would be a causative agent of licorice-induced pseudoaldosteronism.

Authors:  Kan'ichiro Ishiuchi; Osamu Morinaga; Takeshi Ohkita; Chuanting Tian; Asuka Hirasawa; Miaki Mitamura; Yasuhito Maki; Tsubasa Kondo; Tomoya Yasujima; Hiroaki Yuasa; Kiyoshi Minamizawa; Takao Namiki; Toshiaki Makino
Journal:  Sci Rep       Date:  2019-02-07       Impact factor: 4.379

Review 6.  Bioactive Candy: Effects of Licorice on the Cardiovascular System.

Authors:  Mikkel R Deutch; Daniela Grimm; Markus Wehland; Manfred Infanger; Marcus Krüger
Journal:  Foods       Date:  2019-10-14

7.  Identification of an Alternative Glycyrrhizin Metabolite Causing Liquorice-Induced Pseudohyperaldosteronism and the Development of ELISA System to Detect the Predictive Biomarker.

Authors:  Kan'ichiro Ishiuchi; Osamu Morinaga; Tetsuhiro Yoshino; Miaki Mitamura; Asuka Hirasawa; Yasuhito Maki; Yuuna Tashita; Tsubasa Kondo; Kakuyou Ogawa; Fangyi Lian; Keiko Ogawa-Ochiai; Kiyoshi Minamizawa; Takao Namiki; Masaru Mimura; Kenji Watanabe; Toshiaki Makino
Journal:  Front Pharmacol       Date:  2021-05-17       Impact factor: 5.810

8.  Outcomes in patients with nonerosive reflux disease treated with a proton pump inhibitor and alginic acid ± glycyrrhetinic acid and anthocyanosides.

Authors:  Francesco Di Pierro; Mario Gatti; Giuliana Rapacioli; Leandro Ivaldi
Journal:  Clin Exp Gastroenterol       Date:  2013-03-27

9.  Isolation of a novel glycyrrhizin metabolite as a causal candidate compound for pseudoaldosteronism.

Authors:  Osamu Morinaga; Kan'ichiro Ishiuchi; Takeshi Ohkita; Chuanting Tian; Asuka Hirasawa; Miaki Mitamura; Yasuhito Maki; Tomoya Yasujima; Hiroaki Yuasa; Toshiaki Makino
Journal:  Sci Rep       Date:  2018-10-22       Impact factor: 4.379

10.  Compound Ammonium Glycyrrhizin Protects Hepatocytes from Injury Induced by Lipopolysaccharide/Florfenicol through a Mitochondrial Pathway.

Authors:  Wenyang Li; Ying Li; Xiangyuan Jiang; Xiaohui Li; Zugong Yu
Journal:  Molecules       Date:  2018-09-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.